Bdenza Enzalutamide Capsule
Bdenza Enzalutamide Capsule
Bdenza Enzalutamide 40 mg Capsules (112s) is a medication used in the treatment of metastatic castration-resistant prostate cancer (mCRPC) in men who have previously undergone other treatments and experienced disease progression. Enzalutamide belongs to a class of drugs called androgen receptor inhibitors, which work by blocking the action of male hormones (androgens) that stimulate the growth of prostate cancer cells.
Key Information:
-
Indications: Bdenza is prescribed for the treatment of mCRPC in men who have not responded to prior treatments and have shown disease progression.
-
Dosage: The typical recommended dose is 160 mg (four 40 mg capsules) taken once daily, with or without food.
-
Mechanism of Action: By blocking androgen receptors, Bdenza inhibits the signaling of androgens, which slows down the growth and progression of prostate cancer.
Common Side Effects:
- Fatigue
- Back pain
- Headache
- Hot flashes
- High blood pressure
Precautions:
- Bdenza may affect the heart and can cause seizures in some individuals.
- Inform your healthcare provider about any heart conditions or a history of seizures before starting the treatment.
Duration of Treatment:
The length of treatment with Bdenza will depend on your condition and response to the medication. Your healthcare provider will closely monitor your progress and adjust treatment as needed.
Drug Interactions:
Bdenza may interact with medications like blood thinners or those affecting liver enzymes. Always inform your healthcare provider about any other medications or supplements you are currently taking.
Bdenza Enzalutamide 40 mg Capsules offers an effective treatment option for advanced prostate cancer while minimizing the growth of cancer cells.
